Endogenous morphine-like compound immunoreactivity increases in parkinsonism. [electronic resource]
Producer: 20111013Description: 2321-38 p. digitalISSN:- 1460-2156
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine -- pharmacology
- Aged
- Analysis of Variance
- Animals
- Brain -- drug effects
- Choline O-Acetyltransferase -- metabolism
- Chromatography, High Pressure Liquid -- methods
- Dendrites -- metabolism
- Disease Models, Animal
- Dopamine -- metabolism
- Dopamine Agents -- pharmacology
- Dopamine Plasma Membrane Transport Proteins -- deficiency
- Dopamine and cAMP-Regulated Phosphoprotein 32 -- metabolism
- Enzyme Inhibitors -- pharmacology
- Enzyme-Linked Immunosorbent Assay -- methods
- Female
- Functional Laterality
- Gene Expression Regulation -- drug effects
- Glial Fibrillary Acidic Protein -- metabolism
- Glutamate Decarboxylase -- metabolism
- Humans
- Levodopa -- pharmacology
- Macaca fascicularis
- Male
- Medial Forebrain Bundle -- drug effects
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Microscopy, Immunoelectron -- methods
- Middle Aged
- Nerve Growth Factors -- metabolism
- Organic Chemicals -- metabolism
- Oxidopamine -- adverse effects
- Parkinsonian Disorders -- chemically induced
- Postmortem Changes
- Rats
- Rats, Sprague-Dawley
- Receptors, Dopamine D2 -- metabolism
- S100 Calcium Binding Protein beta Subunit
- S100 Proteins -- metabolism
- Tandem Mass Spectrometry
- alpha-Methyltyrosine -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.